HELIOS Kliniken

An update on the current training situation of German interns in oral and maxillofacial surgery at special times in 2021 (2022) Pabst A, Goetze E, Thiem DG, Bartella AK, Seifert L, Beiglboeck FM, Kröplin J, et al. Journal article Endoscopic remission assessed with PICaSSO virtual electronic chromendoscopy accurately predicts clinical outcomes in ulcerative colitis (2022) Nardone OM, Bazarova A, Bhandari P, Cannatelli R, Daperno M, Ferraz J, Goetz M, et al. Journal article Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial) (2022) Welsch T, Muessle B, Korn S, Sturm D, Bork U, Distler M, Graehlert X, et al. Journal article Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale – a bicentric retrospective study (2021) Barz M, Gerhardt J, Bette S, Aftahy AK, Huber T, Combs SE, Ryang YM, et al. Journal article The communication between ocular surface and nasal epithelia in 3d cell culture technology for translational research: A narrative review (2021) Aydin M, Dietrich J, Witt J, Finkbeiner MS, Park JJ, Wirth S, Engeland CE, et al. Journal article, Review article DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status (2021) Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Mueller V, et al. Journal article Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans (2021) Schwarm C, Gola D, Holtsche MM, Dieterich A, Bhandari A, Freitag M, Nürnberg P, et al. Journal article Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Conference contribution Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021) Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al. Conference contribution Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis (2021) Bethge WA, Martus P, Schmitt M, Holtick U, Borchmann P, Subklewe M, Rejeski K, et al. Conference contribution